Pfizer Inc. (PFE) Price Target Analysis
Wall Street analyst price targets, ratings consensus & upside potential · Updated May 1, 2026
Current Price
$26.44
Price Target
$27.27
Target Range
$24.00 — $35.00
Analyst Rating
Hold
Forward P/E8.9x
Trailing P/E19.4x
Forward PEG—
Implied Growth+116.7%
Median Target$27.00
Analyst Spread40.3%
Price Forecast (1 Year)
Last 12 months price action with 12-month analyst target path
Bear Case
$24
-9.2%
Consensus
$27
+3.1%
Bull Case
$35
+32.4%
Valuation Model TargetsConfidence: 55/100
Bear$12
Base$37
Bull$64
PFE Price Target Analysis
Updated May 6, 2026As of May 6, 2026, Pfizer Inc. (PFE) has a Wall Street consensus price target of $27.27, based on estimates from 39 covering analysts. With the stock currently trading at $26.44, this represents a potential upside of +3.1%. The company has a market capitalization of $150.40B.
Analyst price targets range from a low of $24.00 to a high of $35.00, representing a 40% spread in expectations. The median target of $27.00 aligns closely with the consensus average.
The current analyst consensus rating is Hold, with 16 analysts rating the stock as a Buy or Strong Buy,21 rating it Hold, and 2 rating it Sell or Strong Sell. The mixed ratings reflect uncertainty about near-term direction.
From a valuation perspective, PFE trades at a trailing P/E of 19.4x and forward P/E of 8.9x. Analysts expect EPS to grow +116.7% over the next year.
Our proprietary valuation model, which blends historical multiples with forward estimates, suggests a base-case price target of $36.97, with bear and bull scenarios of $12.19 and $64.29 respectively. Model confidence stands at 55/100, reflecting moderate uncertainty in projections.
Investment Context: Price targets represent analyst expectations for the next 12 months and should be considered alongside your own research. Targets are based on analysts' assumptions about earnings growth, margins, and market conditions which may change. For sector-specific context, view other Healthcare stocks.
Analyst Sentiment Comparison
Industry Peer AnalysisAvg Peer Upside+13.8%
Avg Forward P/E17.1x
Peers with Coverage10 / 10
| Company | Market Cap | Price | Target | Upside | Rating | Fwd P/E | Analysts |
|---|---|---|---|---|---|---|---|
 JNJJohnson & Johnson | $543.6B | $225.59 | $249.27 | +10.5% | Buy | 19.5x | 40 |
 MRKMerck & Co., Inc. | $279.5B | $113.16 | $129.31 | +14.3% | Buy | 22.1x | 37 |
 ABBVAbbVie Inc. | $364.6B | $206.15 | $256.64 | +24.5% | Buy | 14.5x | 41 |
 LLYEli Lilly and Company | $933.7B | $988.19 | $1258.47 | +27.4% | Buy | 28.6x | 45 |
 BMYBristol-Myers Squibb Company | $116.2B | $56.92 | $62.00 | +8.9% | Hold | 9.0x | 41 |
 AZNAstraZeneca PLC | $281.0B | $181.24 | $211.00 | +16.4% | Buy | 17.6x | 41 |
 NVSNovartis AG | $277.6B | $145.50 | $141.00 | -3.1% | Hold | 16.6x | 25 |
 AMGNAmgen Inc. | $177.9B | $329.59 | $350.76 | +6.4% | Buy | 14.8x | 38 |
 GILDGilead Sciences, Inc. | $166.3B | $133.48 | $161.88 | +21.3% | Buy | 15.6x | 58 |
 BIIBBiogen Inc. | $27.9B | $189.13 | $211.42 | +11.8% | Buy | 12.9x | 48 |
Upside Potential Comparison
LLYABBVGILDAZNMRKBIIBJNJBMYFull PFE Stock Analysis
Analyst consensus, bull case, AI-generated risk factors, and peer comparison — all in one place.
See PFE's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs PFE Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare PFE vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonPFE — Frequently Asked Questions
Quick answers to the most common questions about buying PFE stock.
What is the PFE stock price target for 2026?
The consensus price target for PFE is $27.27, close to the current price of $26.44 (3.1% implied move). Based on 39 analyst estimates, the stock appears fairly valued near current levels.
Is PFE a buy, sell, or hold?
PFE has a consensus rating of "Hold" based on 39 Wall Street analysts. The rating breakdown is mixed, with 21 Hold ratings making up the largest segment. The consensus 12-month price target of $27.27 implies 3.1% upside from current levels.
Is PFE stock overvalued or undervalued?
With a forward P/E of 8.9294x, PFE trades at a relatively low valuation. The consensus target of $27.27 implies 3.1% appreciation, suggesting the market may be pricing in risks.
How high can PFE stock go?
The most bullish Wall Street analyst has a price target of $35 for PFE, while the most conservative target is $24. The consensus of $27.27 represents the median expectation. Our quantitative valuation model projects a bull case target of $64 based on optimistic growth and margin assumptions. These targets typically reflect 12-month expectations.
How many analysts cover PFE stock?
PFE is heavily covered by Wall Street, with 39 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 16 have Buy ratings, 21 recommend Hold, and 2 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
What is the PFE stock forecast?
The 12-month PFE stock forecast based on 39 Wall Street analysts shows a consensus price target of $27.27, with estimates ranging from $24 (bear case) to $35 (bull case). The median consensus rating is "Hold". Our proprietary valuation model produces a base case fair value of $37, with bear/bull scenarios of $12/$64.
What is PFE's fair value based on fundamentals?
Our quantitative valuation model calculates PFE's fair value at $37 (base case), with a bear case of $12 and bull case of $64. The model uses discounted cash flow analysis, historical growth rates, and margin mean-reversion to project FY+2 earnings, then applies an appropriate P/E multiple. The model confidence score is 55/100.
What is PFE's forward P/E ratio?
PFE trades at a forward P/E ratio of 8.9x based on next-twelve-months earnings estimates compared to a trailing P/E of 19.4x. The lower forward P/E indicates analysts expect earnings growth. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.
Should I buy PFE stock?
PFE appears fairly valued according to analysts, with a "Hold" rating and minimal upside to the $27.27 target. Consider your investment thesis and risk tolerance. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
Why do PFE price targets vary so much?
PFE analyst price targets range from $24 to $35, a 40% moderate spread showing some variance in outlooks. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $27.27 consensus represents the middle ground. Our model's $12-$64 range provides an independent fundamental perspective.